NEW YORK, Nov. 29, 2016 -- Dr. Neil Kaye, Forensic Psychiatrist, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise in the areas of General Psychiatry, Geriatric Psychiatry, Forensic Psychiatry, Neuropsychiatry and Psychopharmacology.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1fad7440-f0b4-430f-ac08-a9064416f391
Dr. Kaye has been active in the healthcare industry for the past 32 years. His private practice focuses on forensic, adult, psychopharmacology, neuropsychiatry, geriatric psychiatry, and new drug research and clinical testing. He specializes in the diagnosis and management of complex psychiatric and neuropsychiatric conditions. He has over 30 years of experience doing clinical research, including evaluation and management of polypharmacy including drug-drug and drug-food interaction profiling, interpretation of chemical/lab results, cardiograms, genetic sampling, and ordering and interpretation of neuroimaging including CT, MRI, fMRI, SPECT, PET.
Dr. Kaye is a third generation physician and was inspired to follow in his father’s footsteps and pursue a career in Psychiatry. He received his MD from Albany Medical College in 1984 and completed his Residency at Albany Medical Center Hospital in 1987. He then completed a Fellowship in Law and Psychiatry at SUNY Upstate.
Dr. Kaye attributes his success to a strong work ethic, a passion for his work in the field of Psychiatry, and a belief in evidenced based practices. He has received numerous honors, including the Golden Apple for teaching, the Red Apple from the American Academy of Psychiatry and the Law and has been a 4-time winner of a Top Doctor Award from Delaware Today Magazine. His day-to-day responsibilities include the diagnosis and treatment of patients within all areas of Adult, Geriatric, and Forensic Psychiatry.
Dr. Kaye is the founder and past chairman of the Task Force on Psychopharmacology and the Law for the American Academy of Psychiatry and the Law, where has also served as a Councilor. He has delivered thousands of lectures in 49 states and internationally and has more than 60 peer-reviewed publications. He is a Past President of the Psychiatric Society of Delaware and currently sits on their Executive Council. He has been an advisor to numerous law enforcement and governmental agencies and remains active in promoting awareness of the interaction of mental health/substance abuse and behavior.
He has no plans of slowing down and expects to remain active clinically as well as legislatively to promote the appropriate care and treatment of people with mental illness and works diligently to break the stigma of mental illness.
Dr. Kaye is a member of the American Psychiatric Association, American Academy of Psychiatry and the Law, Brain Injury Association, and is triple Board Certified by the American Board of Psychiatry. He also is on the Advisory Board of the National Alliance on Mental Illness (Delaware) and the Brain Injury Association of Delaware.
In his free time, Dr. Kaye enjoys cooking, flying helicopters, and spending time with his wife, Dr. Susan Donnelly.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 



